A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA

Clinical trial NCT07604116 · RECRUITING

Trial details

NCT number: NCT07604116
Sponsor: Synusight Biotech (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple System Atrophy (MSA)Parkinson's Disease (PD)

Start date: 2026-06-15
Primary completion: 2026-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.